[ Back to EurekAlert! ]

Contact: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center

Cedars-Sinai Medical Center

Caption: An experimental immune-based therapy more than doubled median survival of patients diagnosed with the most aggressive malignant brain tumor, Cedars-Sinai Medical Center researchers reported in Cancer Immunology, Immunotherapy, published online Aug. 3.

Credit: Cedars-Sinai Medical Center

Usage Restrictions: None

Related news release: Study: Vaccine targets malignant brain cancer antigens, significantly lengthens survival


[ Back to EurekAlert! ]